ClinicalTrials.gov
public full text
Public Domain
A Study of Lasmiditan in Healthy Elderly Participants
The purposes of this study are to evaluate the effect of lasmiditan on blood pressure, as well as to look at the amount of study drug that gets into the blood stream and how long it takes the body to get rid of it in healthy elderly participants. The tolerability of the study drug will also be evaluated. Information about any side effects that may occur will also be collected. This study will take about 11 days, not including screening. Screening is required within 28 days prior to the start of the study.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of Lasmiditan in Healthy Participants#1244821
- A Study of Lasmiditan on the Heart in Healthy Participants#1095514
- A Study of Lasmiditan and Propranolol in Healthy Participants#969285
- A Study of LY3410738 in Healthy Adult Participants#1137973
- A Study Comparing Different Formulations of LY3410738 in Healthy Adult Participants#908248
Record · ID 1394681
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive